If you've been on compounded semaglutide or tirzepatide, here's the short answer: yes, the cheap version is largely gone, and the FDA is working to keep it that way. (See our semaglutide guide.)
This is what happened, what it means for you as of mid-2026, and what you can do next.
What Changed
During the GLP-1 shortage of 2023 and 2024, the FDA let compounding pharmacies make copies of semaglutide and tirzepatide. A compounded drug is a custom-mixed version made by a pharmacy, not the sealed brand product. That made GLP-1 treatment cheaper and easier to get, often at a few hundred dollars a month instead of $1,000 or more. (See our tirzepatide guide.) (See our GLP-1 pricing guide.)
That window has closed. The shortage that made mass compounding legal is over, and the FDA ended its enforcement grace period. Here's the timeline:
- The grace period ended. The FDA stopped allowing routine compounding by 503A pharmacies on February 18, 2025, and by larger 503B outsourcing facilities on March 19, 2025.
- The FDA moved to make it permanent. On April 30, 2026, it proposed to bar semaglutide, tirzepatide, and liraglutide from the list of drugs 503B facilities are allowed to compound in bulk. The public comment window closed June 29, 2026.
- Large-scale compounding has stopped. The telehealth platforms and pharmacies that sold these copies at scale have mostly wound down.
What This Means for Patients
If you were relying on compounded semaglutide or tirzepatide: (See our telehealth GLP-1 providers.)
- Routine cheap compounding is done. This isn't a coming change. It has already happened, and the FDA is trying to lock it in for good.
- A narrow exception remains. A pharmacy can still make a patient-specific version, but only with a documented medical reason: an allergy to an ingredient in the brand product, or a dose the brand doesn't sell. This is not a cheap workaround for the general public.
- Don't stockpile. Compounded peptides have shelf-life and storage limits, so hoarding is risky and wasteful.
- Have a backup plan now. Talk to your provider before your current supply runs out.
Your Options Going Forward
1. Switch to Brand-Name Medication
Brand-name Wegovy and Zepbound are easy to get now. The list price is steep (Wegovy runs about $1,000 to $1,300 a month, Zepbound about $1,086), but there are real ways to bring that down:
- Insurance and savings cards. If your plan covers weight loss, a manufacturer savings card can drop your cost to as little as $25 a month. See our insurance coverage guide.
- Self-pay programs. NovoCare offers the Wegovy pens for $349 a month and the Wegovy pill from $149, and LillyDirect offers Zepbound vials for $299 to $449 a month, no insurance needed.
- Medicare. Since July 1, 2026, Medicare Part D covers Wegovy and Zepbound for obesity at a $50 copay for those who qualify. See our Medicare coverage guide.
2. Explore the Oral GLP-1 Option
The oral semaglutide (Wegovy pill) launched in 2025 and is at many pharmacies. Your insurance may cover it differently than the shot, and the pricing works out better for some people. (See our GLP-1 insurance coverage guide.) (See our savings calculator.)
3. Ask About Other Medications
Other weight loss drugs are still available. Saxenda (liraglutide) is another GLP-1 option, and non-GLP-1 drugs like Contrave and Qsymia are prescribed at plenty of clinics. (See our liraglutide guide.)
4. Find a Clinic That Carries Multiple Options
What matters most right now is a provider who can shift your plan as costs and coverage change. Clinics that offer more than one medication, not just a single brand, are best set up to keep your treatment going without a gap.
How to Protect Yourself
A few rules for the new normal:
- Talk to your provider now. Get ahead of it instead of waiting to run out.
- Check your coverage. Brand-name and Medicare GLP-1 coverage have both expanded in 2026. Your plan may cover more than you'd guess.
- Be wary of miracle replacements. As compounded GLP-1s dry up, some sellers will push unproven peptides and supplements as substitutes. Stick with FDA-approved medications from licensed providers.
Find a Provider Who Can Help You Adjust
The GLP-1 market is changing fast. STAT News tracks the compounding rules and pricing in real time if you want to follow along. Your best move is to work with a provider who stays on top of the changes and can offer you more than one path forward.
Search our directory to find weight loss clinics with full GLP-1 programs, and browse clinics by state to find one near you. Filter by medication type to match a provider to what you need.